CD8A and myeloid sarcoma: However, the fact that the HLA-class I alleles HLA-A*0301 and HLA-A*0201 are risk-increasing or protective, respectively (5, 6), and the greater abundance and invasiveness of CD8+ T cells in acute and chronic MS lesions (7, 8), also support a role of these cells in MS.